Blog Posts

Latest research from Wistar described age-related structural changes in our skin and lymphatic system that favor the spread of melanoma; showed promise for a novel DNA vaccine for Ebola and engineered, DNA-based checkpoint inhibitors for cancer immunotherapy; and characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression.

Utilizing the momentum from Vice President Joe Biden’s national Cancer Moonshot initiative in 2016, Dr. Jill Biden led a special summit in Philadelphia capitalizing on exciting local research and placing a spotlight on survivors and their stories. Progress and Promise Against Cancer, hosted by the American Association for Cancer Research (AACR) and WHYY brought together cancer research and healthcare leaders, advocates, and patients to tell their stories and speed advances with the goal of eliminating cancer. 
 

Celebrating the scientists and donors responsible for a year of game-changing discovery.

In this fourth annual Rugart Family Award top honors are bestowed on three Wistar trainees. 

Wistar scientists conquered new frontiers in DNA vaccines for infectious diseases, and developed a combination immunotherapy that enhances efficacy of immune checkpoint blockade therapy in pre-clinical studies.